Page 41 - Success Story

BIRAC Success Stories | 2016 Shantani Proteome Analytics

Key Highlights

* Launched the technology in 2013.
Breakthrough * Wide client base spanning from India
to global big bio-pharma, chemical
• Developed a robust Drug-Target and FMCG companies located in North
Identification Technology Platform. America and Europe.
• Unique Polymer Technology (UPT), * Type-2 Diabetes drug discovery program
which can reduce the drug-target at pre-IND stage with IND enabling
identification efforts to a month from studies planned.
3 to 6 months. * 3 international patents filed.
• Platform is being used for drug target
identification, toxicity profiling of new
lead-molecules and drug repurposing.
• Development of Type-2-diabetes drug
discovery program.
• Poised for pre-clinical testing of a
molecule for its anti-diabetic potential.

BIRAC’s Support

Received SBIRI grant for technology
substantiation and identification of a
new drug target for treating Type-2-
Diabetes.

41